The burgeoning trend in diabetes care is undoubtedly centered around GLP-1 therapies, and BrightMeds is leading this wave . These groundbreaking drugs, initially developed for treating type 2 diabetes, are now commonly prescribed – or being explored – for their impressive ability to promote reduced body fat and improve metabolic health. BrightM